Clinical Trial Update: A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update announcing ongoing recruitment for a study of risankizumab in young participants with ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• SKYRIZI (risankizumab-rzaa)

Snippet

Sponsor: AbbVie | Conditions: Ulcerative Colitis | Phase 3 | Status: RECRUITING